|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
614 The proteomic classifier VeriStrat® identifies advanced non small cell lung cancer (NSCLC) patients gaining clinical benefit from treatment with first line sorafenib and erlotinib |
Vir: |
|
|
|
|
List of services to meet your request
Contains list of services for current record
Basic services |
|
|
© 2024 SFX by Ex Libris Inc. | Politika piškotkov
CrossRef Omogočeno
|